CN105919907A - 中药眼霜制作方法及其眼霜 - Google Patents
中药眼霜制作方法及其眼霜 Download PDFInfo
- Publication number
- CN105919907A CN105919907A CN201511030394.6A CN201511030394A CN105919907A CN 105919907 A CN105919907 A CN 105919907A CN 201511030394 A CN201511030394 A CN 201511030394A CN 105919907 A CN105919907 A CN 105919907A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- eye
- blood
- eye cream
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 94
- 239000006071 cream Substances 0.000 title claims abstract description 55
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- 210000001508 eye Anatomy 0.000 claims abstract description 183
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 238000004821 distillation Methods 0.000 claims abstract description 6
- 239000013078 crystal Substances 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 25
- 229940079593 drug Drugs 0.000 claims description 22
- 230000008901 benefit Effects 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 17
- 241001057584 Myrrha Species 0.000 claims description 17
- 210000000582 semen Anatomy 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- 239000000706 filtrate Substances 0.000 claims description 15
- 210000001015 abdomen Anatomy 0.000 claims description 14
- 241000717739 Boswellia sacra Species 0.000 claims description 13
- 239000004863 Frankincense Substances 0.000 claims description 13
- 241000180649 Panax notoginseng Species 0.000 claims description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 239000000758 substrate Substances 0.000 claims description 12
- 241001489978 Eupolyphaga Species 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 229910000831 Steel Inorganic materials 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000005325 percolation Methods 0.000 claims description 6
- 239000010959 steel Substances 0.000 claims description 6
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 5
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229960000502 poloxamer Drugs 0.000 claims description 5
- 229920001983 poloxamer Polymers 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 241000143437 Aciculosporium take Species 0.000 claims description 2
- 238000010410 dusting Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims 1
- 240000002853 Nelumbo nucifera Species 0.000 claims 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 125000005456 glyceride group Chemical group 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 107
- 210000004369 blood Anatomy 0.000 abstract description 101
- 230000017531 blood circulation Effects 0.000 abstract description 38
- 230000000694 effects Effects 0.000 abstract description 33
- 230000008961 swelling Effects 0.000 abstract description 26
- 230000001717 pathogenic effect Effects 0.000 abstract description 10
- 230000007102 metabolic function Effects 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 239000003053 toxin Substances 0.000 abstract description 5
- 231100000765 toxin Toxicity 0.000 abstract description 5
- 238000000605 extraction Methods 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 4
- 240000007311 Commiphora myrrha Species 0.000 abstract description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 2
- 238000002481 ethanol extraction Methods 0.000 abstract description 2
- 210000000056 organ Anatomy 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 241001633993 Cineraria Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 230000008016 vaporization Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 47
- 230000001737 promoting effect Effects 0.000 description 31
- 208000002193 Pain Diseases 0.000 description 28
- 230000036407 pain Effects 0.000 description 28
- 210000003734 kidney Anatomy 0.000 description 20
- 231100000614 poison Toxicity 0.000 description 18
- 230000004438 eyesight Effects 0.000 description 16
- 206010030113 Oedema Diseases 0.000 description 13
- 241000475481 Nebula Species 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 238000012423 maintenance Methods 0.000 description 12
- 206010013935 Dysmenorrhoea Diseases 0.000 description 11
- 230000032683 aging Effects 0.000 description 11
- 239000002537 cosmetic Substances 0.000 description 11
- 241000700199 Cavia porcellus Species 0.000 description 10
- 229960004756 ethanol Drugs 0.000 description 10
- 208000014674 injury Diseases 0.000 description 10
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 201000000736 Amenorrhea Diseases 0.000 description 9
- 206010001928 Amenorrhoea Diseases 0.000 description 9
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 9
- 208000005171 Dysmenorrhea Diseases 0.000 description 9
- 206010052139 Eye oedema Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 231100000540 amenorrhea Toxicity 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 210000000744 eyelid Anatomy 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000001575 pathological effect Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 244000025254 Cannabis sativa Species 0.000 description 7
- 208000019255 Menstrual disease Diseases 0.000 description 7
- 230000001276 controlling effect Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 208000003351 Melanosis Diseases 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 238000010612 desalination reaction Methods 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- 230000002175 menstrual effect Effects 0.000 description 5
- 230000004089 microcirculation Effects 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 206010040872 skin infection Diseases 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 230000035617 depilation Effects 0.000 description 4
- 230000002951 depilatory effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 208000014617 hemorrhoid Diseases 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 230000008326 skin blood flow Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 210000002435 tendon Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 240000006409 Acacia auriculiformis Species 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 241001608538 Boswellia Species 0.000 description 3
- 241000459479 Capsula Species 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 244000131316 Panax pseudoginseng Species 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 208000003464 asthenopia Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- -1 filters Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 230000028161 membrane depolarization Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 230000004206 stomach function Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 235000018062 Boswellia Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 235000002673 Dioscorea communis Nutrition 0.000 description 2
- 241000544230 Dioscorea communis Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000521257 Hydrops Species 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000150100 Margo Species 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000035753 Periorbital contusion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 240000003152 Rhus chinensis Species 0.000 description 2
- 235000014220 Rhus chinensis Nutrition 0.000 description 2
- 206010050637 Skin tightness Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010251 cutis laxa Diseases 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000007443 liposuction Methods 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001427554 Corydiidae Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241000907904 Dipterocarpus Species 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000237537 Ensis Species 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 241000195952 Equisetaceae Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 240000007171 Imperata cylindrica Species 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 208000007379 Muscle Hypotonia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 241001396014 Priacanthus arenatus Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 241000274582 Pycnanthus angolensis Species 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 241000208225 Rhus Species 0.000 description 1
- 241000581682 Sanguisorba Species 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 241000580955 Sapindus mukorossi Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 241001146210 Senecio scandens Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000003718 aged appearance Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000011512 eye pigmentation Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- XRRQZKOZJFDXON-UHFFFAOYSA-N nitric acid;silver Chemical compound [Ag].O[N+]([O-])=O XRRQZKOZJFDXON-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000003319 supportive effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000000264 venule Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种缓解眼袋的中药眼霜的制作方法,所述制作方法包括以下步骤:a.取薄荷、没药、千里光、白芨、白芷与冰片用蒸馏法汽化成结晶,粉碎过细筛待用,作为组分1;b.将剩余原料药用乙醇萃取,合并浓缩提取液;c.将上述步骤乙醇萃取过的提取液浓缩成浸膏,作为组分2;d.将组分1与组分2混合后加基质调和,杀菌装罐。本发明扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体眼周皮肤血液循环,从而达到消肿祛瘀、缓解疲劳、紧致眼部肌肤、淡化眼袋,美化容貌的目的。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物组份的美容配制品,特别涉及一种缓解眼袋的中药眼霜及其制作方法。
背景技术
爱美之心人皆有之,可脸上挂个大眼袋估计是谁心情都不好。眼袋是一种非常讨厌的脂肪堆积,它严重影响人们的美观,有眼袋的人看起来老态龙钟,眼袋是指下睑部组织臃肿,呈袋状垂挂。框内脂肪容量与下睑支持性结构在正常情况下维持平衡状态,当这种平衡由于眶内脂肪堆积过多或下睑支持结构变薄弱而发生改变时,眶内脂肪突破下睑的限制突出于眶外,即形成下睑袋状畸形。临床表现为下睑皮肤松弛、堆积,眶内脂肪脱出垂挂呈袋状,外眦位置下移,下睑缘与眼球贴合不紧密,下睑缘弧度增加,下泪点外移溢泪,面部骨骼的老化吸收导致下睑支持结构继发松弛,是中老年眼袋形成的主要原因。
眼袋是由于皮肤松弛所造成的。这种认识有很大的代表性。经过论证,也是眼袋产生的主要原因。所以,提升皮肤紧致度是主要的改善途径。比较理想的方式是口服胶原蛋白。但是不要奢望在短时间内彻底改善,因为眼袋的修复是需要一定的过程的。
眼袋的加重是由于脂肪过多引起。这也是极具代表性的认识,眶隔脂肪有其正常的生理功能,其主要功能是保护眼球。同时也是形成眼袋的原因之一。之所以形成“囊袋样”外观,完全是由于眶隔膜的张力减退所致。这种眼袋的去除方法就是进行手术抽脂。如果手术抽脂后,而不进行眶隔膜的修复,后果必然会导致眼袋复发。如果大量取出脂肪,那必然造成下睑的凹陷,加重衰老外观。
化妆品能矫治眼袋。这要从两个方面来分析,如果是“功能性”眼袋,也就是说眼袋时而明显,时而不明显。适当应用营养霜类化妆品对于防止眼袋的加重是能起到一定作用的。而一旦眼袋是“病理性”的,也就是组织结构发生了改变,而且眼袋长期显现,并逐渐加重。如果想通过化妆品来矫正,那完全是徒劳的。对眼睛保养必须提前做好,眼袋除极少病理性因素外生理因素占绝大部分,大量女性在身体状况的情况下忽视对眼睛保养的需求,导致开始发生衰老后速度非常之快,在衰老之前有意识的进行养护非常重要。
眼袋的出现与加重是面部皮肤衰老的标志之一。要想完全避免眼袋的发 生,是不现实也是不可能的。因为衰老是自然规律,是无法抵抗的。但只要稍加注意,是完全有可能延缓及预防眼袋的发生的。
致眼袋出现有六个原因
1、脾胃功能减弱,会导致体内积水,致使下眼睑松弛,形成眼袋。
2、肝是排毒和造血系统之一,肝开窍于目,肝的问题全表现在双眼处,若肝无法排清毒素,就会形成眼袋。
3、肾虚会发生体液代谢障碍,肾气不足,日久导致气血不畅,出现眼袋。
4、从经络学来看,下眼睑走胃经,眼袋的位置是胃经的承泣穴和四白穴所在。体液代谢功能出现衰退,胃机能变差,令承泣穴和四白穴阻塞所造成的。
5、眼部周围的血液循环容易因过劳而变得淤滞,血管由于淤塞而回流不畅,造成淋巴代谢减缓,使多余的水分及血液积聚在眼睛下方,继而形成眼袋。
6、肌肤缺水严重,肌肤的每个细胞都需要足够的养分,当肌肤长期没有足够的水分子来撑起时,也会导致肌肤变的松弛,导致眼袋出现或者加重。
中医理论认为大部分眼部浮肿的发生与肝肾虚有关,肝肾虚后,肾精不能养肝血,而“肝开窍于目”,最终因精血亏损,表现在双眼上就形成黑眼圈,眼部水肿。而现代研究也证实眼部浮肿是由于经常熬夜,情绪不稳定,眼部疲劳、衰老,导致静脉血管血流速度过于缓慢,眼部皮肤红血球细胞供氧不足,静脉血管中二氧化碳及代谢废物积累过多,形成慢性缺氧,血液较暗并形成滞留以及造成眼部色素沉着,以及眼部浮肿。这与中医理论是相吻合的。眼袋可以通过手术矫正。激光也能改善眼袋,促进皮肤的新陈代谢,促进血液的循环、淋巴循环,使深深的眼袋慢慢的淡化,大约一个疗程以后就会看到明显的激光美容去眼袋的效果。激光去眼袋是属于无创美容的,不需要麻醉,激光去眼袋在进行治疗后会个别的有局部红肿的现象,这属于正常的现象,如果配合好眼部周围的护理和日常的保养,效果会更加的持久,但价格昂贵,并且有一定的风险,不是每个人都能负担的起。
发明内容
本发明所要解决的技术问题在于,随着年纪的增长,脾胃功能减弱,会导致体内积水,致使下眼睑松弛,形成眼袋;肝开窍于目,肝的问题全表现在双眼处,若肝无法排清毒素,就会形成眼袋。肾虚会发生体液代谢障碍,肾气不足,日久导致气血不畅,出现眼袋。
临床激光虽有一定疗效,但价格昂贵,有不同程度的副作用或引起某些并发症;而中药制品则因其取材天然、安全性好、低副作用、文献资料丰富、临床疗效佳而备受青睐。但现有的方剂针对性差,不能从根本上缓解眼袋, 并且还有一定的副作用。因此,寻找一种高效安全的中药眼霜成为人们的迫切需求。
为解决这些技术难题,本发明提供了一种缓解眼袋的中药眼霜,其所述中药眼霜中可以包括以下重量份数的原料药:盐肤木10~20份,木贼10~20份,无患子10~20份,千里光10~20份,没药10~20份,丹参10~20份,桃仁10~20份,三七10~20份,白茅根10~20份,红花10~20份,地榆10~20份,白芨10~20份,薄荷10~20份,冰片10~20份,白芷10~20份,乳香10~20份,仙鹤草10~20份,土鳖虫10~20份,当归10~20份。
所述缓解眼袋的中药眼霜,其所述中药眼霜中原料药的重量份数还可以为:盐肤木10~15份,木贼10~15份,无患子10~15份,千里光10~15份,没药10~15份,丹参10~15份,桃仁10~15份,三七10~15份,白茅根10~15份,红花10~15份,地榆10~20份,白芨10~20份,薄荷10~20份,冰片10~20份,白芷10~20份,乳香10~20份,仙鹤草10~20份,土鳖虫10~20份,当归10~20份。
所述缓解眼袋的中药眼霜,其所述中药眼霜中原料药的重量份数也可以为:盐肤木10~20份,木贼10~20份,无患子10~20份,千里光10~20份,没药10~20份,丹参10~20份,桃仁10~20份,三七10~20份,白茅根10~20份,红花10~20份,地榆10~15份,白芨10~15份,薄荷10~15份,冰片10~15份,白芷10~15份,乳香10~15份,仙鹤草10~15份,土鳖虫10~15份,当归10~15份。
为解决上述技术问题,本发明还提供一种缓解眼袋的中药眼霜的制作方法,其所述制作方法包括以下步骤:
a.取薄荷、没药、千里光、白芨、白芷与冰片用蒸馏法汽化成结晶,粉碎过细筛待用,作为组分1;
b.将剩余原料药用乙醇萃取,合并浓缩提取液;
c.将上述步骤乙醇萃取过的提取液浓缩成浸膏,作为组分2;
d.将组分1与组分2混合后加基质调和,杀菌装罐。
所述步骤a中,可以先将原料药薄荷、没药、千里光、白芨、白芷与冰片用水蒸气法蒸馏,得到结晶物,然后粉碎,过100-120目筛,作为组分1备用。
所述步骤b中,可以将其余原料药切碎,将其浸泡置于有盖不锈钢桶内,加70%乙醇液,质量为粗颗粒的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放 料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,静置备用。
所述步骤c中,可以将上述步骤提取的提取液,放入双效真空浓缩器中混合,先将滤液浓缩至80℃时相对密度为1.32的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g浸膏,成组分2。
所述步骤d中,可以将组分1投入组分2中,搅拌均匀,加热,调和基质,成霜剂。
所述步骤e中,所述基质选自:聚山梨酯-80、三乙醇胺、丙二醇,半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种。
所述缓解眼袋,眼部浮肿的中药眼霜,其使用方法是,每次临睡前洁面后,将眼霜均匀涂抹于眼周,并用中指指肚在眼周按摩15-20分钟,至其充分吸收后,第二天早起洗去。
本发明参考古今中医学药理研究成就,筛选补气活血、清肝明目、滋肝补肾、明目退翳、平肝潜阳、清热解毒、消肿除水的天然中药,扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体眼周皮肤血液循环,从而达到消肿祛瘀、缓解疲劳、紧致眼部肌肤。淡化眼袋,美化容貌的目的。本发明根据传统中医理论及现代药理研究结果,反复筛选外用药,配制成中药眼霜,具有活血祛瘀、明目退翳、温通血脉,活肤消肿,养血祛斑,紧致肌肤的功效。能有效扩张末梢血管,改善面部眼周微循环,消肿祛瘀,对色素沉着有一定的抑制作用。本发明治疗效果较理想,且无毒安全,制作方法简便易行,能创造良好的社会效益与经济效益。
具体实施方式
化妆品能矫治眼袋。这要从两个方面来分析,如果是“功能性”眼袋,也就是说眼袋时而明显,时而不明显。适当应用营养霜类化妆品对于防止眼袋的加重是能起到一定作用的。而一旦眼袋是“病理性”的,也就是组织结构发生了改变,而且眼袋长期显现,并逐渐加重。如果想通过化妆品来矫正,那完全是徒劳的。对眼睛保养必须提前做好,眼袋除极少病理性因素外生理因素占绝大部分,大量女性在身体状况的情况下忽视对眼睛保养的需求,导致开始发生衰老后速度非常之快,在衰老之前有意识的进行养护非常重要。其出色的保养能效能在皮肤表面形成轻薄如纱的湿润皮脂膜,产生卓越的保湿效果,保持肌肤年轻湿润。
祖国医学认为,本病发生的内因与肝、脾、肾三脏以及气血运行的失常关系密切,因此内治在脏腑多从肝脾肾论治,但也是身体内部平衡失调的外在反映。所以在治疗上要从整体出发,辨证施治。肝脾精血充盈、冲任调畅, 则血络自有载药之资。肝主疏泄,能调达气血,舒畅情志。若肝气郁结则气血失和.气滞血瘀。壅滞络脉,上结于面则致面斑。肝主藏血。肝血充和,则体健面润。若肝肾不足,精血亏虚,不能上荣则易生面斑。
中医气血理论认为,气血循环过程是人体一切组织器官进行工作的物质基础,气血以流畅平衡为贵,如果气血不流畅就会产生瘀血,瘀血阻于体内,将进一步导致气血循环的恶化,造成更严重的瘀塞,故中医以气血为纲,通过调气活血使之流畅平衡,可祛病强身、养血美容。皮肤斑点之根本在瘀,退斑必先祛瘀、祛瘀当须活血,活血更须补气、理气,气为血之帅,血随之而运行;血为气之守,气得之而静谧,气结则血凝,气虚则血脱,气迫则血走。气血和则俱和。而理气在肝,补气在肺肾,肺主皮毛。因气滞血瘀,影响到肺脾肝肾的气血运行功能,而致面部出现黄褐斑、黑眼圈、眼袋、眼部浮肿、雀斑等色斑,甚至出现头发脱落、斑秃。本发明主要根据传统中医学辨正施治的原理,集众医家所长,广采博收地区奇药妙方,提取精华;选取补气活血、清肝明目、滋肝补肾、明目退翳、平肝潜阳、清热解毒、消肿除水的天然中药,扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体眼周皮肤血液循环,从而达到消肿祛瘀、缓解疲劳、紧致眼部肌肤。淡化眼袋,美化容貌的目的。
白芍入肝、脾经,养血柔肝,缓中止痛,敛阴收汗。治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下,妇人血闭不通,消瘀血,能蚀脓,益女子血。《日华子本草》:治风、补劳,主女人一切病,并产前后诸疾,通月水,退热,除烦,益气,天行热疾,瘟瘴,惊狂,妇人血运,及肠风,泻血,痔瘘。发背,疮疥,头痛,明目,目赤努肉。赤色者多补气,白者治血。
白芨性苦、甘、涩,微寒。归肺、肝、胃经。功能主治收敛止血,消肿生肌。用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。《神农本草经》:“主痈肿、恶疮、败疽,伤阴死肌,胃中邪气”;《本草纲目》:“气味(根)苦、平、无毒。
白芷性味归经:辛,温。归肺、胃经。祛风散寒,通窍止痛,消肿排脓,燥湿止带。《日华子本草》:治目赤胬肉,及补胎漏滑落,破宿血,补新血,乳痈、发背、瘰疬、肠风、痔瘘,排脓,疮痍、疥癣,止痛生肌,去面皯疵瘢。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。《纲目》载:丹参,按《妇人明理论》云,四物汤治妇人病,不问产前产后,经水多少,皆可通用,惟一味丹参散,主治与之相同。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。丹参主要成 分丹参酮有扩张血管、改善循环、解除血管内凝血等作用,具有活血化痕之功效,并能促进肝脏血液循环,利于肝细胞再生。
薄荷,土名叫“银丹草”,为唇形科植物,即同属其他干燥全草,多生于山野湿地河旁,根茎横生地下,是一种有特种经济价值的芳香作物。全株青气芳香。叶对生,花小淡紫色,唇形,花后结暗紫棕色的小粒果。薄荷是中华常用中药之一。它是辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症。处用可治神经痛、皮肤瘙痒、皮疹和湿疹等。薄荷是中国常用中药,幼嫩茎尖可作菜食,全草又可入药,治感冒发热喉痛,头痛,目赤痛,肌肉疼痛,皮肤风疹搔痒,麻疹不透等症,此外对痈、疽、疥、癣、漆疮亦有效。薄荷含有薄荷醇,该物质可清新口气并具有多种药性,可缓解腹痛、胆囊问题如痉挛,还具有防腐杀菌、利尿、化痰、健胃和助消化等功效。大量食用薄荷可导致失眠,但小剂量食用却有助于睡眠。
没药(Commiphora myrrha Engl.),又名末药,为橄榄科植物地丁树或哈地丁树的干燥树脂。主产于非洲索马里、埃塞俄比亚以及印度等地。采集由树皮裂缝处渗出的白色油胶树脂,于空气中变成红棕色而坚硬的圆块。打碎后,炒至焦黑色应用。主治胸腹瘀痛、痛经、经闭、症瘕、跌打损伤、痈肿疮疡、肠痈、目赤肿痛。有活血止痛、消肿生肌等功效。在东方是一种活血、化瘀、止痛、健胃的中药,湿寒性或黏液质性疾病,如湿寒性关节疼痛,坐骨神经痛,口腔疼痛,咽喉疼痛,寒性咳嗽,湿性痰多,支气管扩张,湿疹脓疮,月经不调,小便不利。《注医典》:“生发固发,祛斑消痕,软坚除瘤,除癣愈创,固齿健龈,解毒等。治脱发毛细,黑斑伤痕,扁平疣,各种湿疹,牙龈糜烂,毒虫叮伤等。”没药配伍红花,没药活血止痛,红花活血祛淤通经。二者合用,有活血、祛淤、通经、止痛之功效,用於治疗血淤所致之心腹疼痛、痛经、产后淤阻腹痛及跌打损伤之淤滞疼痛。
木贼药用为木贼科植物木贼的全草,木贼(拉丁学名:Equisetum hyemale L.)别称:千峰草、锉草、笔头草、笔筒草、接骨草、马人参等。木贼味甘、苦,性平。归肺、肝经,具有疏散风热、明目退翳、止血的功效。木贼夏季采收,除去杂质,晒干或阴干贮藏,药用炮制:除去枯茎及残根,喷淋清水,稍润,切段,干燥。切断段。疏风散热,解肌,退翳。治目生云翳,迎风流泪,肠风下血,血痢,脱肝,疟疾,喉痛,痈肿。《嘉祜本草》:主目疾,退翳膜。又消积块,益肝胆,明目,疗肠风,止痢及妇人月水不断。《纲目》:解肌,止泪,止血,去风湿,疝痛,大肠脱肛。
红花(拉丁学名:Carthamus tinctorius L.),别名:红蓝花、刺红花,菊科、红花属植物,干燥的管状花,橙红色,花管狭细,先端5裂,裂片狭线形,花药黄色,联合成管,高出裂片之外,其中央有柱头露出。具特异香气,味微苦。以花片长、色鲜红、质柔软者为佳。活血通经,散瘀止痛,有助于治经闭、痛经、恶露不行、胸痹心痛、瘀滞腹痛、胸胁刺痛、跌打损伤、疮疡肿痛疗效。有活血化瘀,散湿去肿的功效。
冰片,又名片脑、桔片、艾片、龙脑香、梅花冰片、羯布罗香、梅花脑、冰片脑、梅冰等,是由菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸汽蒸馏并重结晶而得。亦有用松节油经一系列化学方法工艺而得。其可用于闭证神昏、用于目赤肿痛,喉痹口疮、用于疮疡肿痛,溃后不敛等《新修本草》:“主心腹邪气,风湿积聚,耳聋,明目,去目赤肤翳。”《本草纲目》:“疗喉痹、脑痛、鼻瘜、齿痛、伤寒舌出、小儿痘陷。通诸窍,散郁火。”《医林纂要》:“冰片主散郁火,能透骨热,治惊痫、痰迷、喉痹,舌胀、牙痛、耳聋、鼻息、目赤浮翳、痘毒内陷、杀虫、痔疮、催生,性走而不守,亦能生肌止痛。
桃仁(Semen Persicae),可指桃核里的仁儿;作为中草药桃仁使用时,特指蔷薇科植物桃或山桃的种子,别名毛桃仁、扁桃仁、大桃仁,6~7月果实成熟时采摘,除去果肉及核壳,取出种子,晒干,有活血祛瘀、润肠通便的功效,可用于经闭、痛经、癓瘕痞块、跌扑损伤、肠燥便秘等。孕妇慎用。临床观察证明,桃仁对血流阻滞、血行障碍有改善作用,能使各脏器各组织机能恢复正常。
三七是以其根部入药,其性温,味辛,具有显著的活血化瘀、消肿定痛功效,有“金不换”、“南国神草”之美誉。因常在春冬两季采挖,又分为“春七”和“冬七”。清朝药学著作《本草纲目拾遗》中记载:“人参补气第一,三七补血第一,味同而功亦等,故称人参三七,为中药中之最珍贵者。”扬名中外的中成药“云南白药”和“片仔癀”,即以三七为主要原料制成。主治咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛。
千里光(Senecio scandens Buch.-Ham.ex D.Don),又名九里明、九里光、黄花母、九龙光、九岭光。是一种中草药,生于山坡、疏林下、林边、路旁、沟边草丛中。产于河南、陕西、江苏、浙江、广西、四川。其性寒,味苦,具有清热解毒,明目,止痒等功效。多用于风热感冒、目赤肿痛、泄泻痢疾、皮肤湿疹疮疖。
无患子(拉丁学名:Sapindus mukorossi Gaertn.),果皮含有皂素,可代肥皂,木材可做箱板和木梳等。根、嫩枝叶、种子:苦、微辛,寒。有小毒。清热祛痰,消积杀虫。用于白喉,咽喉肿痛,乳蛾,咳嗽,顿咳,食滞虫积;外用于阴道滴虫。种仁:辛,平。消积辟恶。用于疳积,蛔虫病,腹中气胀,口臭。抑菌、去屑、防脱、美白去斑、滋润皮肤的作用:“无患子可预防头皮屑”,这对于惯用传统的、天然的洗护用品的中国人来说,根本就是普通常识。使用无患子皂乳洗头,对於预防掉发据民间传说也有效。无患子中的茶多酚是水溶性物质,用它洗脸能清除面部的油脂、收敛毛孔,能消毒、灭菌、抗皮肤老化,能减少日光中紫外线辐射对皮肤的损伤等。无患子中的阿魏酸是科学界公认的美容因子,能改善皮肤质量,使其细腻、光泽、富有弹性。同时还有抗菌、消炎、抗氧化、清除自由基、抗凝血等作用。无患子中的果酸能帮助皮肤去除堆积在外层的老化角质。
盐肤木,拉丁名Rhus chinensis Mill.是良好的蜜源植物。根、叶、花及果均可入药,有清热解毒、舒筋活络、散瘀止血、涩肠止泻之效。漆树科植物盐肤木Rhus chinensis Mill.以根、叶入药。根:入药为“盐麸子根”,有驱风,化湿,消肿,软坚的功效;治感冒发热,咳嗽,腹泻,水肿,风湿痹痛,跌打伤肿,乳痈,癣疮,消酒毒。去掉栓皮的根皮为“盐麸根白皮”,有祛风湿,散瘀血,清热解毒的功效;治咳嗽,风湿骨痛,水肿,黄胆,跌打损伤,肿毒疮疥,蛇咬伤等。
白茅根,中药名。为禾本科植物白茅Imperata cylindrica Beauv.var.major(Nees)C.E.Hubb.的干燥根茎。春、秋二季采挖,洗净,晒干,除去须根和膜质叶鞘,捆成小把。《本经》:劳伤虚羸,补中益气,除瘀血、血闭寒热,利小便。《别录》:下五淋,除客热在肠胃,止渴坚筋,妇人崩中。久服利人。《本草纲目》:止吐衄诸血,伤寒哕逆,肺热喘急,水肿黄胆,解酒毒。
地榆(拉丁学名:Sanguisorba officinalis L.)是蔷薇科地榆属多年生草本植物,地榆也是中草药。性寒,味苦酸,无毒;归肝、肺、肾和大肠经。有凉血止血,清热解毒,培清养阴,消肿敛疮等功效。《本经》:主妇人七伤,带下病,止痛,除恶肉,止汗,疗金疮。《别录》:止脓血,诸痿,恶疮,消酒,除消渴,补绝伤,产后内塞,可作金疮膏。主内漏不止,血不足。《药性论》:止血痢蚀脓。
乳香,中药名。为橄榄科植物乳香树Boswellia carterii Birdw.及同属植物Boswellia bhaurdajiana Birdw.树皮渗出的树脂。《本草纲目》:“消痈疽诸毒,托里护心,活血定痛,治妇人难产,折伤。”“乳香香窜,能入心经,活血定痛,故为痈疽疮疡、心腹痛要药。......产科诸方多用之,亦取其活血之功耳。”本草汇言》:“乳香,活血祛风,舒筋止痛之药也。......又跌仆斗打,折伤筋骨,又产后气血攻刺,心腹疼痛,恒用此,成取其香辛走散,散血排脓,通气化滞为专功也。”
仙鹤草,仙鹤草为蔷薇科植物龙芽草的全草夏秋两季采割,切断生用入药。中医认为,其性味苦涩而平,有收敛止血,补虚,消积,止痢,杀虫,解毒消肿等功效,多用来治疗咯血、吐血等多种出血症,泄泻,痢疾,疮疖痈肿,蛔虫、绦虫等虫证以及脱力劳伤,神疲乏力,面色萎黄等证。
土鳖虫,中药名。为鳖蠊科昆虫地鳖Eupolyph,aga sin,ensis Walker或冀地鳖Steleophaga Plancyi(Boleny)的雌虫干燥体。具有破血逐瘀,续筋接骨之功效。用于跌打损伤,筋伤骨折,血瘀经闭,产后瘀阻腹痛,瘾瘕痞块。
当归补血;活血;调经止痛;润燥滑肠。主血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。当归气轻而辛,故又能行血,既可通经调经,又能活络止痛,尤其适合女性使用,特别适合月经不调、痛经、血虚闭经等病证,被古人称为“妇科圣药”。与桃仁、红花、熟地黄、白芍、川芎配伍,组成妇 科名方——桃红四物汤,常用于经期提前、痛经。
具体实施例1
将薄荷1000g、没药1000g、千里光1000g、白芷1000g、白芨1000g、冰片1000g用蒸馏法汽化成结晶,粉碎待用,为组分1;其他原料盐肤木1000g,木贼1000g,无患子1000g,丹参1000g,桃仁1000g,三七1000g,白茅根1000g,红花1000g,地榆1000g,乳香1000g,仙鹤草1000g,土鳖虫1000g,当归1000g,用水浸泡,加热煮沸3次,每次1-2小时,过滤,滤液备用;将合并后3次的滤液抽入减压浓缩罐内,减压浓缩至相对密度为1.20,温度至60℃-70℃的浸膏;成为组分2,混合组分1和组分2,调和基质,成凝胶剂;所述基质选自:聚山梨酯-80、三乙醇胺、丙二醇,半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种,调成眼霜用紫外线灭菌装瓶。
具体实施例2
将薄荷1200g、没药1200g、千里光1200g、白芷1200g、白芨1200g、冰片1200g用蒸馏法汽化成结晶,粉碎待用,为组分1;其他原料盐肤木1200g,木贼1300g,无患子1200g,丹参1300g,桃仁1200g,三七1200g,白茅根1300g,红花1200g,地榆1300g,乳香1300g,仙鹤草1200g,土鳖虫1200g,当归1200g,加占其质量7-10倍的乙醇浸泡2-3小时,加热提取2次,每次1-2小时,合并提取液,静置后去上清液,然后100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.25的滤液。再将上述乙醇提取过的原料药的药渣加10倍量水,加热回流提取2次,每次1~2小时,将2次提取液合并静置,超滤液减压浓缩相对密度为80℃时1.25的滤液,混合两种提取滤液置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,成为组分2。将组分1和组分2的合并,加入珍珠粉末1300g,调和基质,成凝胶剂;所述基质选自:聚山梨酯-80、三乙醇胺、丙二醇,半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种,调成眼霜用紫外线灭菌装瓶。
具体实施例3
将薄荷1200g、没药1200g、千里光1200g、白芷1200g、白芨1200g、冰片1200g用蒸馏法汽化成结晶,粉碎待用,为组分1;取其他原料盐肤木1200g,木贼1300g,无患子1200g,丹参1300g,桃仁1200g,三七1200g,白茅根1300g,红花1200g,地榆1300g,乳香1300g,仙鹤草1200g,土鳖虫1200g,当归1200g,将其浸泡置于有盖不锈钢桶内,加70%乙醇液,质量为粗颗粒的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙 醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,静置备用;将过滤的滤液置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g生药量,为组分2。将组分1和组分2的合并,加入珍珠粉末1300g,调和基质,成凝胶剂;所述基质选自:聚山梨酯-80、三乙醇胺、丙二醇,半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种,调成眼霜用紫外线灭菌装瓶。
药理学毒性试验
急性毒性实验资料
1、实验方法
将豚鼠背部脊柱两侧将脱毛剂均匀涂上,使去毛范围约40平方厘米。洗净脱毛剂归笼观察24小时,每组豚鼠分别涂本发明中药眼膜0.2、0.4和0.8ml,分别含生药92mg、184mg和368mg),另一组涂溶媒0.8ml每日二次,连续一周,实验结束后,将豚鼠处死,心,肝,肾及脱毛皮肤做病理检验。
2、结果
上述三组用药豚鼠躯干脱毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组豚鼠毛发色泽、摄食、四肢活动等对照组无明显差异,病理组织学检查,给药组心、肝、肾及脱毛皮与对照字比较也无明显差异。
结果提示,本发明中药眼膜无局部刺激作用,也未见全身毒性表现。表明本发明中药眼膜使用安全。
长期毒性实验资料
1、实验方法
将豚鼠随机份成4组,每组15只。在豚鼠背部脊柱两侧将脱毛剂均匀涂上,使其脱毛范围约40平方厘米。洗净脱毛剂,观察24小时后每组豚鼠分别涂本发明眼膜0.2、0.4和0.8ml,分别含生药92、184和368mg),另一组涂溶媒0.8ml每日二次,连续30天,观察豚鼠的一般情况,实验结束后处死动物进行血液学、血液生化及病理学检查。
2、结果
上述三组用药豚鼠躯干去毛区,未见局部皮肤有水肿、充血、红斑、出血点及溃疡。用药组与对照组动物毛发色泽、摄食、四肢活动等对照组无明显差异,血液生化检查,用药组与对照组均在正常范围。病理组织学检查,实验各组心、肝、肾及局部皮肤均未见明显病变。提示,本发明中药眼膜长期用药对局部皮肤及全身重要脏器均未见明显的毒性作用。试验结果表明:本发明中药眼膜实验安全。
药理学实验
一、本发明的微循环实验方法:
1、材料与方法:取50只小鼠,随机分成5组,每组10只(雌雄各半),对照组每鼠右耳涂生理盐水少许;阳性对照组每鼠右耳给予市售佰草集新七白眼霜(上海佰草集化妆品有限公司出品),受试组分为本发明外用眼霜400mg/kg/h。15min后腹腔注射0.1%戊巴比妥钠0.1ml/10g麻醉动物,随后尾静脉注射0.1%肾上腺素0.1mL/10g,立即观察小鼠右耳微动静脉口径(μm)及0.2mm2毛细血管网点数.t检验处理实验数据.
2结果与讨论
2.1.对微循环的影响
与对照组相比,受试组1对小鼠毛细血管开放数有明显增多(P<0.01);受试组2对微静脉口径和毛细血管开放数有显著增加(P<0.01);受试组3对小鼠微动、静脉口径及毛细血管开放数皆有增加(P<0.01);说明受试药能改善微循环,有活血化瘀作用(表1)。
表1、本发明眼膜对小鼠微动、静脉口径及毛细血管开放数的影响
二、对巴豆油所致小鼠耳廓肿胀的影响
取健康小鼠30只,随机分成3组,即空白对照组、新七白眼霜阳性对照组、本发明眼霜组,每组10只,雌雄各半,阳性对照组和本发明组分别涂抹,空白对照组涂抹等剂量的生理盐水,连续给药7天,于末次给药后0.5小时,在小鼠左耳内外测涂巴豆油致炎剂(2%巴豆油,20%无水乙醇,5%蒸馏水,73%乙醚)0.1ml致炎,致炎后4小时用打孔器(孔径6mm)打下左、右耳片,称重,以左右耳片重量差作为肿胀程度,结果见表2。
表2对巴豆油所致小鼠耳廓肿胀的影响(X±SD)
组别 | 动物数(只) | 肿胀度(mg) |
空白对照组 | 10 | 8.51±1.72 |
新七白眼霜组 | 10 | 5.64±1.59** |
本发明眼霜组 | 10 | 4.12±1.36# |
注:与对照组比较:**P<0.01;与阳性对照组比较:#P<0.05;由上表实验结果可以看出,本发明眼霜具有更好的消肿药理作用。
三.对角叉菜胶所致大鼠足跖肿胀的影响
取健康大鼠30只,体重180-220g,随机分成空白对照组、新七白眼霜阳性对照组、本发明眼霜组。每组10只,雌雄各半,分笼饲养。阳性对照组和本发明药物组分别每日涂抹0.2g,空白对照组给予同剂量的生理盐水涂抹,连续给药7天,于末次给药后30分钟,分别在大鼠右后足跖皮下注射1%角叉菜胶混悬液0.1ml/只致炎,分别于致炎前和致炎后15、30、60、120、240分钟测大鼠右后足跖的周长,并计算肿胀率【肿胀率=(致炎后足跖周长-致炎前足跖周长)/致炎前足跖周长×100%】;结果见表3。
表3对角叉菜胶所致大鼠足跖肿胀的影响(X±SD)
注:与对照组比较:**P<0.01;与阳性对照组比较:#P<0.05;由上表实验结果可以看出,本发明药物组具有更好的消肿祛瘀的药理作用。
3讨论
中医理论认为大部分眼袋的发生与肝肾虚有关,肝肾虚后,肾精不能养肝血,而“肝开窍于目”,最终因精血亏损,表现在双眼上就形成上下眼皮浮肿,眼袋很大。而现代研究也证实眼袋是由于经常熬夜,情绪不稳定,眼部疲劳、衰老,导致静脉血管血流速度过于缓慢,眼部皮肤红血球细胞供氧不足,静脉血管中二氧化碳及代谢废物积累过多,形成慢性缺氧,血液较暗并形成滞留以及造成眼部眼袋、眼部浮肿的出现,这与中医理论是相吻合的。
眼袋是由于皮肤松弛所造成的。这种认识有很大的代表性。经过论证,也是眼袋产生的主要原因。所以,提升皮肤紧致度是主要的改善途径。比较理想的方式是口服胶原蛋白。但是不要奢望在短时间内彻底改善,因为眼袋的修复是需要一定的过程的。
化妆品能矫治眼袋。这要从两个方面来分析,如果是“功能性”眼袋,也就是说眼袋时而明显,时而不明显。适当应用营养霜类化妆品对于防止眼袋的加重是能起到一定作用的。而一旦眼袋是“病理性”的,也就是组织结构发生了改变,而且眼袋长期显现,并逐渐加重。如果想通过化妆品来矫正,那完全是徒劳的。对眼睛保养必须提前做好,眼袋除极少病理性因素外生理因素占绝大部分,大量女性在身体状况的情况下忽视对眼睛保养的需求,导致 开始发生衰老后速度非常之快,在衰老之前有意识的进行养护非常重要。
眼袋形成后应对症下药,请教医生,找出病因,及时治疗;要保持精神愉快,减少精神负担,生活有规律,节制烟酒,保障充足的睡眠,促使气血旺盛,容颜焕发;加强眼部的按摩,改善局部血液循环状态,减少淤血滞留;如涂含油分、水分充足的眼霜,使眼部皮肤及皮下组织充满活力,淡化眼袋,眼部水肿。
本发明参考古今中医学药理研究成就,筛选补气活血、清肝明目、滋肝补肾、明目退翳、平肝潜阳、清热解毒、消肿除水的天然中药,扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体眼周皮肤血液循环,从而达到消肿祛瘀、缓解疲劳、紧致眼部肌肤。淡化眼袋,美化容貌的目的。本发明根据传统中医理论及现代药理研究结果,反复筛选外用药,配制成中药眼霜,具有活血祛瘀、明目退翳、温通血脉,活肤消肿,养血祛斑,紧致肌肤的功效。能有效扩张末梢血管,改善面部眼周微循环,消肿祛瘀,对色素沉着有一定的抑制作用。
临床试验
说明:我院于2014年5月-2015年5月,使用自制眼霜治疗眼袋、眼部浮肿,疗效显著,现报道如下。
临床资料:临床选取眼袋明显者100例。其中男28人,女性72人。年龄28-58岁,平均35.2岁;未婚者32例,已婚者68例,已育者21例;病程6个月-12年,平均5.33年;教育水平大学文化86人,白领、教师、干部、科室人员55例,其他人员30例。自述经常熬夜打游戏45例,遗传35倒,失眠20例,每日保养眼周者67人,激光治疗眼袋复发12人。临床分为治疗组50例,对照组50例。
治疗方法:治疗组采用自制中药眼霜,方用:盐肤木15g,木贼12g,无患子11g,千里光12g,没药10g,丹参12g,桃仁12g,三七13g,白茅根14g,红花12g,地榆12g,白芨12g,薄荷11g,冰片12g,白芷13g,乳香13g,仙鹤草13g,土鳖虫12g,当归11g。按实施例3的方法制作成眼霜。
取眼霜对照组,每组50例,分别使用市售的佰草集新七白眼霜。
操作过程:进行时人员平卧床上,用3%双氧水清洁面部,用负离子喷雾器喷雾面部,同时配合经络穴位按摩十二法进行面部按摩,眼周局部做重点按摩,时间约10min.后取眼霜,均匀涂于眼皮四周,注意不要弄进眼睛,可适当按摩10-15分钟。每日一次,1个月为1疗程。疗程结束后,每月随访1次,连续随访3个月。治疗期间嘱病人注意休息,并停用其它眼霜,眼霜。
疗效标准
痊愈:治疗2疗程后,眼袋、眼部浮肿明显消失,且疗效维持1个月以上,眼疲劳缓解;有效:眼袋明显变淡,消退50%以上,病人自觉满意,睡眠质量好;或治疗期间眼袋消失,但随访中睡眠不好,加班又有复发;无效:眼袋、眼部浮肿改变不明显或无变化;或曾消退50%以上,但随访中明显加重,试 验人员不满意。
治疗结果:治疗组总有效率与各对照组比较,差别均有显著性(P<0.01),说明自制眼霜疗效明显优于市售眼霜。详见表1
表1 3组疗效对比表
注:与其他各组比较*P<0.01
随访结果随访发现,按摩者强于不按摩的人士。复发后,若继续使用仍然有效。
说明:本发明参考古今中医学药理研究成就,筛选补气活血、清肝明目、滋肝补肾、明目退翳、平肝潜阳、清热解毒、消肿除水的天然中药,扶正祛邪,通腑泄毒,活血散瘀,调节人体的新陈代谢机能,提高人体眼周皮肤血液循环,从而达到消肿祛瘀、缓解疲劳、紧致眼部肌肤。淡化眼袋,美化容貌的目的。本发明根据传统中医理论及现代药理研究结果,反复筛选外用药,配制成中药眼霜,具有活血祛瘀、明目退翳、温通血脉,活肤消肿,养血祛斑,紧致肌肤的功效。能有效扩张末梢血管,改善面部眼周微循环,消肿祛瘀,对色素沉着有一定的抑制作用。
Claims (10)
1.一种缓解眼袋的中药眼霜的制作方法,其特征在于,所述制作方法包括以下步骤:
a.取薄荷、没药、千里光、白芨、白芷与冰片用蒸馏法汽化成结晶,粉碎过细筛待用,作为组分1;
b.将剩余原料药用乙醇萃取,合并浓缩提取液;
c.将上述步骤乙醇萃取过的提取液浓缩成浸膏,作为组分2;
d.将组分1与组分2混合后加基质调和,杀菌装罐。
2.根据权利要求1所述缓解眼袋的中药眼霜的制作方法,其特征在于,所述步骤a中,先将原料药薄荷、没药、千里光、白芨、白芷与冰片用水蒸气法蒸馏,得到结晶物,然后粉碎,过100-120目筛,作为组分1备用。
3.根据权利要求1所述缓解眼袋的中药眼霜的制作方法,其特征在于,所述步骤b中,将其余原料药切碎,将其浸泡置于有盖不锈钢桶内,加70%乙醇液,质量为粗颗粒的0.8-1倍,搅拌均匀,湿润密闭放置1小时以上,使充分膨胀;将渗漉筒底部滤板用纱布袋包裹铺平后再将湿润膨胀后的药物样品拌松弄散,然后用不锈钢勺盛粉,均匀的装入渗漉筒,装10-12厘米厚,用T型棒压匀,再按上述操作,一层一层的装入,适当加压,药粉填装不得超过渗漉筒的2/3高处;药粉面上盖不锈钢孔板压牢,打开渗漉筒下面的放料阀,并放一容器,然后缓缓加入70%乙醇液;待排出药粉粉粒之间的空气,并有乙醇流出约20L左右,关闭放料阀,盖上漉筒、浸渍24小时,然后开放料阀进行渗漉,控制渗漉速度一般为1000g药材每分钟流出2~3ml,滤液放入贮液缸内,并将排空时的乙醇液倒入贮液缸;将渗滤液合并静置,静置备用。
4.根据权利要求1所述缓解眼袋的中药眼霜制作方法,其特征在于,所述步骤c中,将上述步骤提取的提取液,放入双效真空浓缩器中混合,先将滤液浓缩至80℃时相对密度为1.32的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含0.1g浸膏,成组分2。
5.根据权利要求1所述缓解眼袋的中药眼霜制作方法,其特征在于,所述步骤d中,将组分1投入组分2中,搅拌均匀,加热,调和基质,成霜剂。
6.根据权利要求1所述缓解眼袋的中药眼霜制作方法,其特征在于,所述步骤e中,所述基质选自:聚山梨酯-80、三乙醇胺、丙二醇,半合成脂肪酸甘油酯、泊洛沙姆、聚乙二醇、羊毛脂中的一种或多种。
7.一种中药眼霜,其特征在于,包括以下重量份数的原料药:盐肤木10~20份,木贼10~20份,无患子10~20份,千里光10~20份,没药10~20份,丹参10~20份,桃仁10~20份,三七10~20份,白茅根10~20份,红花10~20份,地榆10~20份,白芨10~20份,薄荷10~20份,冰片10~20份,白芷10~20份,乳香10~20份,仙鹤草10~15份,土鳖虫10~15份,当归10~15份。
8.根据权利要求7所述中药眼霜,其特征在于,所述中药眼霜中各种原料药的重量份数为:盐肤木10~15份,木贼10~15份,无患子10~15份,千里光10~15份,没药10~15份,丹参10~15份,桃仁10~15份,三七10~15份,白茅根10~15份,红花10~15份,地榆10~20份,白芨10~20份,薄荷10~20份,冰片10~20份,白芷10~20份,乳香10~20份,仙鹤草10~15份,土鳖虫10~15份,当归10~15份。
9.根据权利要求7所述中药眼霜,其特征在于,所述中药眼霜中各种原料药的重量份数为:盐肤木10~15份,木贼10~20份,无患子10~20份,千里光10~20份,没药10~20份,丹参10~20份,桃仁10~20份,三七10~20份,白茅根10~20份,红花10~20份,地榆10~15份,白芨10~15份,薄荷10~15份,冰片10~15份,白芷10~15份,乳香10~15份,仙鹤草10~15份,土鳖虫10~15份,当归10~15份。
10.根据权利要求6~9中任一项所述缓解眼袋的中药眼霜,其特征在于,使用方法是,每次临睡前洁面后,将眼霜均匀涂抹于眼周,并用中指指肚在眼周按摩15-20分钟,至其充分吸收后,第二天早起洗去。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030394.6A CN105919907A (zh) | 2015-12-31 | 2015-12-31 | 中药眼霜制作方法及其眼霜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511030394.6A CN105919907A (zh) | 2015-12-31 | 2015-12-31 | 中药眼霜制作方法及其眼霜 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105919907A true CN105919907A (zh) | 2016-09-07 |
Family
ID=56840270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511030394.6A Pending CN105919907A (zh) | 2015-12-31 | 2015-12-31 | 中药眼霜制作方法及其眼霜 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105919907A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108653005A (zh) * | 2018-06-26 | 2018-10-16 | 广州市瓷颜化妆品有限公司 | 眼膏、该眼膏的制备方法及眼膏组合装置 |
CN112402352A (zh) * | 2020-12-10 | 2021-02-26 | 杭州宝尔科技有限公司 | 一种缓解视疲劳预防度数加深的保健美容眼霜 |
-
2015
- 2015-12-31 CN CN201511030394.6A patent/CN105919907A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108653005A (zh) * | 2018-06-26 | 2018-10-16 | 广州市瓷颜化妆品有限公司 | 眼膏、该眼膏的制备方法及眼膏组合装置 |
CN112402352A (zh) * | 2020-12-10 | 2021-02-26 | 杭州宝尔科技有限公司 | 一种缓解视疲劳预防度数加深的保健美容眼霜 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203B (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
CN102847063B (zh) | 一种治疗气血两虚血瘀型糖尿病足的中药组合物及其制备方法 | |
CN103751635A (zh) | 一种治疗黄褐斑的中药面膜及其制备方法 | |
CN103432475B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN105342908A (zh) | 一种缓解皱纹的积雪草中药美容抗皱膏及其制备方法 | |
CN105496917A (zh) | 一种积雪草抗皱面霜及其制备方法 | |
CN103751633A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN105616318A (zh) | 一种抗皱紧肤的积雪草中药面膜及其制备方法 | |
CN103749824B (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
CN104922051A (zh) | 一种缓解眼角皱纹眼袋的中药眼霜及其制备方法 | |
CN106580838A (zh) | 一种中药美白淡斑精华及其制备方法 | |
CN106074959A (zh) | 一种缓解黑眼圈的中药组合物及其制备方法 | |
CN105616317A (zh) | 一种缓解眼部皱纹、眼袋的积雪草眼霜及其制备方法 | |
CN106667852A (zh) | 一种中药祛痘霜及其制备方法 | |
CN105919907A (zh) | 中药眼霜制作方法及其眼霜 | |
CN105920379A (zh) | 一种缓解眼袋的中药眼霜及其制备方法 | |
CN105998246A (zh) | 一种治疗足跟痛的中药外用膏剂及其制备方法 | |
CN105342954A (zh) | 一种具有活肤化瘀去黄去斑的中药面膜及其制备方法 | |
CN105395766A (zh) | 一种防治脱发促进头发再生的中药制剂 | |
CN104958235A (zh) | 一种缓解眼疲劳黑眼圈的中药眼膜及其制备方法 | |
CN105663700A (zh) | 抗皱美容膏制作方法及其美容膏 | |
CN105616984A (zh) | 一种益母草去皱美容膏及其制备方法 | |
CN105534854A (zh) | 一种祛除鱼尾纹及眼袋的眼霜及其制备方法 | |
CN105213999A (zh) | 一种温经止痛的丹参叶保健茶及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160907 |
|
RJ01 | Rejection of invention patent application after publication |